Description

TIGLIP is an oral antidiabetic medicine containing teneligliptin, used to manage type 2 diabetes mellitus. It works by increasing incretin activity, which helps increase insulin release and reduce glucagon secretion when blood glucose is elevated, supporting better blood glucose control.

TIGLIP-M SR is a combination antidiabetic medicine used to manage type 2 diabetes mellitus. Teneligliptin helps increase insulin release and reduce glucagon secretion when blood glucose is elevated, while metformin reduces glucose production by the liver and improves insulin sensitivity, providing complementary blood glucose control.